JLens 500 Jewish Advocacy U.S. ETF (NYSEARCA:TOV – Get Free Report) saw a large drop in short interest during the month of July. As of July 15th, there was short interest totaling 1,905 shares, a drop of 92.8% from the June 30th total of 26,434 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 3,863 shares, the days-to-cover ratio is presently 0.5 days.
Institutional Investors Weigh In On JLens 500 Jewish Advocacy U.S. ETF
Several hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. acquired a new position in shares of JLens 500 Jewish Advocacy U.S. ETF in the third quarter valued at approximately $25,000. Bank of New York Mellon Corp increased its stake in shares of JLens 500 Jewish Advocacy U.S. ETF by 66.7% during the first quarter. Bank of New York Mellon Corp now owns 71,189 shares of the company’s stock worth $1,946,000 after purchasing an additional 28,496 shares during the period. Finally, Captrust Financial Advisors acquired a new stake in JLens 500 Jewish Advocacy U.S. ETF during the 2nd quarter worth approximately $6,038,000.
JLens 500 Jewish Advocacy U.S. ETF Stock Performance
Shares of TOV stock traded up $0.01 during midday trading on Friday, hitting $31.05. 330 shares of the company were exchanged, compared to its average volume of 11,932. The firm has a market capitalization of $261.13 million, a P/E ratio of 25.69 and a beta of 1.03. The firm’s 50 day moving average price is $31.42 and its two-hundred day moving average price is $29.82. JLens 500 Jewish Advocacy U.S. ETF has a 52 week low of $26.19 and a 52 week high of $32.04.
JLens 500 Jewish Advocacy U.S. ETF Company Profile
The JLens 500 Jewish Advocacy U.S. ETF (TOV) is an exchange-traded fund that is based on the JLens 500 Jewish Advocacy U.S. index. The fund tracks an index of large-cap US stocks while employing a methodology that seeks to align stock selection and weighting with Jewish value pillars. TOV was launched on Feb 26, 2025 and is issued by JLens.
Further Reading
- Five stocks we like better than JLens 500 Jewish Advocacy U.S. ETF
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for JLens 500 Jewish Advocacy U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JLens 500 Jewish Advocacy U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
